RHONE-POULENC RORER PAKISTAN (PVT) LTD. (ANIMAL HEALTH DIV.)

Rhone-Poulenc Rorer Pakistan (Pvt) Ltd. (Animal Health Div.), identifying its likely business type, presented entirely in English:

Company Introduction: Rhone-Poulenc Rorer Pakistan (Pvt) Ltd. (Animal Health Division)

Overview:

Rhone-Poulenc Rorer Pakistan (Pvt) Ltd., specifically its Animal Health Division, was the Pakistani operation of the global pharmaceutical and chemical company Rhône-Poulenc Rorer. This division focused exclusively on the veterinary sector within Pakistan.

Business Focus:

The Animal Health Division was dedicated to providing products and solutions for the health and productivity of livestock (such as cattle, sheep, goats), poultry, and potentially companion animals in Pakistan. Their portfolio likely included:

Veterinary pharmaceuticals (medicines for treating diseases)

Vaccines (for disease prevention)

Nutritional supplements and feed additives

Possibly other animal health management products

Nature of Business (Manufacturer vs. Trader):

As a division of a major multinational pharmaceutical company (Rhône-Poulenc Rorer), this entity would primarily be classified as a manufacturer and marketer. While they might have imported some specialized finished products or active ingredients, large pharmaceutical subsidiaries like this typically engage in:

1. Local Manufacturing/Formulation: Producing finished veterinary products locally from imported or locally sourced raw materials.

2. Packaging: Packaging bulk products into market-ready formats.

3. Marketing & Sales: Promoting and selling their products through distribution networks across Pakistan.

4. Technical Support: Providing expertise and support to veterinarians and farmers.

Therefore, while some trading activities might have occurred, its core identity and operations were centered around manufacturing (or at least significant local value addition like formulation and packaging) and marketing its own brand of animal health products within Pakistan.

Historical Context:

It is crucial to note that the parent company, Rhône-Poulenc Rorer, underwent significant changes through mergers.

In 1999, Rhône-Poulenc merged with Hoechst Marion Roussel to form Aventis.

In 2004, Aventis merged with Sanofi-Synthélabo to form Sanofi-Aventis (now known simply as Sanofi).

Consequently, the entity "Rhone-Poulenc Rorer Pakistan (Pvt) Ltd." no longer exists under this name. Its operations, assets, and product lines would have been integrated into the successor companies, likely Aventis Pakistan Ltd. and subsequently Sanofi Pakistan Ltd. The animal health business itself may have seen further changes, potentially becoming part of Sanofi's animal health unit or being divested (e.g., elements related to Merial, which Sanofi later acquired fully and then exchanged with Boehringer Ingelheim).

In Summary:

During its operational period, Rhone-Poulenc Rorer Pakistan (Pvt) Ltd. (Animal Health Division) was a key player in the Pakistani veterinary market, acting primarily as a manufacturer and marketer of animal health solutions, leveraging the global resources and reputation of its parent company. Its legacy continues within the structure of Sanofi Pakistan or potentially other companies that acquired specific business lines.

the information presented in English.

It's important to note that Rhône-Poulenc Rorer's animal health division underwent significant changes globally. It merged with Merck's animal health business to form Merial in 1997. Merial was later fully acquired by Sanofi, and subsequently, Sanofi's animal health business (Merial) was acquired by Boehringer Ingelheim in 2017.

Therefore, Rhône-Poulenc Rorer Pakistan (Pvt) Ltd. (Animal Health Div.) as an entity operating under that specific name likely does not actively market products today. The products originally developed or marketed by them would now likely be part of the Boehringer Ingelheim Animal Health portfolio in Pakistan.

Historically, companies like Rhône-Poulenc Rorer (and its successor Merial) would have produced or sold a range of veterinary products in Pakistan, typically including:

1. Parasiticides:

Anthelmintics (dewormers) for livestock (cattle, sheep, goats) and poultry.

Ectoparasiticides for controlling ticks, mites, lice, and flies on livestock.

Antiprotozoals for treating blood parasites (e.g., Trypanosomiasis, Babesiosis, Theileriosis). Examples might have included products based on Diminazene Aceturate or Imidocarb Dipropionate.

Products for companion animals (dogs/cats) like flea and tick treatments. Historically, this could include early generation products related to brands like Frontline (Fipronil) which originated from Rhône-Mérieux.

2. Vaccines:

Vaccines for livestock against diseases like Foot-and-Mouth Disease (FMD), Hemorrhagic Septicemia (HS), Black Quarter (BQ).

Poultry vaccines against diseases such as Newcastle Disease (ND), Infectious Bursal Disease (Gumboro), Infectious Bronchitis (IB).

Rabies vaccines for companion animals and potentially livestock.

3. Anti-infectives:

Various antibiotics for treating bacterial infections in livestock and poultry (Injectables, water-soluble powders, intramammary infusions). Examples might include formulations based on Oxytetracycline, Penicillin/Streptomycin combinations.

4. Therapeutics & Other Products:

Anti-inflammatory drugs.

Nutritional supplements or metabolic enhancers.

To find the current products available in Pakistan that originated from this lineage, you would need to look at the portfolio offered by Boehringer Ingelheim Animal Health Pakistan.